Pan Drugs Ltd
₹
None%
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
TTM | |
---|---|
25.10 | |
25.00 | |
Operating Profit | 0.10 |
OPM % | 0.40% |
0.49 | |
Interest | 0.03 |
Depreciation | 1.28 |
Profit before tax | -0.72 |
Tax % | |
-0.72 | |
EPS in Rs | -2.28 |
Dividend Payout % |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -26% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -1540% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Equity Capital |
Reserves |
Total Liabilities |
CWIP |
Investments |
Total Assets |
Cash Flows
Figures in Rs. Crores
Net Cash Flow |
Ratios
Figures in Rs. Crores
Debtor Days |
Inventory Days |
Days Payable |
Cash Conversion Cycle |
Working Capital Days |
ROCE % |
Documents
Announcements
- Shareholding for the Period Ended December 31, 2017 8 Jan 2018
- Shareholding for the Period Ended September 30, 2017 16 Oct 2017
- Shareholding for the Period Ended June 30, 2017 16 Oct 2017
- Statement Of Investor Complaints For The Quater Ended June,2017 14 Oct 2017
- PCS Certificate For Transfer/Transmission For The Quater Ended September,2017 14 Oct 2017
Annual reports
No data available.